drugset / Trial / NCT04938609
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)
Phase 2
Active not recruiting
28 enrolled
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy of neoadjuvant immunoradiotherapy (NIRT) prior to surgery for the treatment of stage III and IVA HPV- HNSCC.
Timeline
- Start
- 2022-01-11
- Primary completion
- 2027-01-11
- Completion
- 2031-01-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pembrolizumab | Monoclonal antibody | — | — |